Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil

Radiation Research

Volumn 145, Issue 5, 1996, Pages 624-631

  Neta, Ruth ^a,d   Keller, Jonathan R ^b   Ali, Nasima ^a   Blanchette, Francois ^c   Dubois, Claire M ^c  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF SHERBROOKE   (Canada)

^d U S DEPARTMENT OF ENERGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; SPLEEN CELL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; BONE MARROW CELLS; CELLS, CULTURED; COBALT RADIOISOTOPES; COLONY-FORMING UNITS ASSAY; FEMALE; FLUOROURACIL; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-1; KINETICS; MICE; MICE, INBRED STRAINS; RADIATION, IONIZING; RADIATION-PROTECTIVE AGENTS; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; WHOLE-BODY IRRADIATION;

ANIMALIA;

EID: 0029986470     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579282     Document Type: Article

References (48)

1. R. Neta, S. D. Douches and J. J. Oppenheim. Interleukin-1 is a radioprotector. J. Immunol 136, 2483-2485 (1986).
2. H. Futami, R. Jansen, M. J. MacPhee, J. R. Keller, K. McCormick, D. L. Longo, J. J. Oppenheim, F. W. Ruscetti and R. H. Wiltrout, Chemoprotective effects of rhIL-1α in normal and tumor-bearing mice: Protection from acute toxicity, hematotogical effects, development of late mortality and enhanced therapeutic efficacy. J. Immunol. 145, 4120-4130 (1990).
3. G. Damia, K. L. Komschlies, H. Futami, T. Back, M. E. Gruys, D. L. Longo, J. R. Keller, F. W. Ruscetti and R. H. Wiltrout, Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: Protection from hematological and nonhematological toxicities. Cancer Res. 52, 4082-4089 (1992).
4. D. H. Lynch, A. S. Rubin, R. E. Miller and D. E. Williams, Protective effects of recombinant human interleukin-1α in doxorubicin-treated normal and tumor-bearing mice. Cancer Res. 53, 1565-1570 (1993).
5. R. Neta and J. J. Oppenheim, IL-1: Can we exploit Jekyll and subjugate Hyde? In Biologic Therapy of Cancer Updates (V. De Vita and S. Rosenberg, Eds.), Vol. 2, pp. 1-11. J. B, Lippincott, Philadelphia, 1992.
6. L. L. Miller and R. Neta, Therapeutic utility of cytokines in counteracting the bone marrow suppression of radio- and chemo-therapy. In Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis and Therapy (A. Gearing, J. Rossio and J. J. Oppenheim, Eds.), pp. 225-236. Oxford University Press, Oxford, 1993.
7. M. A. S. Moore and D. J. Warren, Synergy of interleukin-1 and granulocyte colony stimulating factor: In vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc. Natl. Acad. Sci. USA 84, 7134-7138 (1987).
8. D. Y. Mochizuki, J. R. Eisenmart, P. J. Conlon, A. D. Larsen and R. J. Tushinski, Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hematopoietin 1. Proc. Natl. Acad. Sci. USA 84, 5267-5271 (1987).
9. M. O. Muench, J. G. Schneider and M. A. S. Moore, Interactions among colony-stimulating factors, IL-1β, IL-6 and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp. Hematol. 20, 339-349 (1991).
10. G. C. Bagby, C. A. Dinarello, P. Wallace, C. Wagner, S. Hefeneider and E. McCall, Interleukin-1 stimulates granulocyte-macrophage colony-stimulating activity release by vascular endothelial cells. J. Clin. Invest. 78, 1316-1323 (1986).
11. 2. J. Clin. Invest. 77, 1857-1863 (1986).
12. K. Kaushansky, N. Lin and J. W. Adamson, Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanisms for the hematopoietic response to inflammation. J. Clin. Invest. 81, 92-97 (1988).
13. S. N. Vogel, S. D. Douches, E. N. Kaufman and R. Neta, Induction of colony stimulating factor in vivo by recombinant interleukin-1 α and recombinant tumor necrosis factor α. J. Immunol. 138, 2143-2148 (1987).
14. K. Hestdal, E. W. Jacobsen, F. W. Ruscetti, C. M. Dubois, D. L. Longo, R. Chizzonite, J. J. Oppenheim and J. R. Keller, In vivo effect of interleukin-1α on hematopoiesis; Role of colony stimulating factor receptor modulation. Blood 80, 2486-2494 (1992).
15. C. S. Johnson, D. J. Keckler, M. I. Topper, P. G. Braunschweiger and P. Furmanski, In vivo hematopoietic effects of recombinant interleukin 1 in mice: Stimulation of granulocytic, monocytic, megakaryocytic and early erythroid progenitors: suppression of late stage erythropoiesis and reversal of erythroid suppression with erythropoietin. Blood 73, 678-683 (1989).
16. M. P. Castelli, P. L. Black, M. Schneider, R. Pennington, F. Abe and J. E. Talmadge, Protective, restorative and therapeutic properties of recombinant human IL-1 in rodent models. J. Immunol. 140, 3830-3837 (1988).
17. R. Neta, J. J. Oppenheim, J. M. Wang, C. M. Snapper, M. A. Moorman and C. M. Dubois. Synergy of IL-1 and c-kit ligand (KL) in radioprotection of mice correlates with IL-1 upregulation of mRNA and protein expression for c-kit on bone marrow cells. J. Immunol. 153, 1536-1543 (1994).
18. W. K. Sinclair and R. A. Morton, X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat. Res. 29, 450-474 (1966).
19. J. Denekamp, Cell kinetics and radiation biology. Int. J. Radiat. Biol. 49, 357-380 (1986).
20. H. R. Withers, K. Mason, B. O. Reid, N. Dubraysky, H. T. Barkley, B. W. Brown and J. B. Smathers, Response of mouse intestine to neutrons and gamma rays in relation to dose fraction and cell cycle. Cancer 34, 39-47 (1974).
21. C. N. Schwartz, T. J. MacVittie, R. M. Vigneulle, M. L. Patchen, S. D. Douches. J. J. Oppenheim and R. Neta, Enhanced hematopoietic recovery in irradiated mice pretreated with interleukin-1 Immunopharmacol. Immunotoxicol. 9, 371-389 (1987).
22. R. Neta, M. B. Sztein, J. J. Oppenheim, S. Gillis and S. D. Douches, In vivo effects of IL-1. I. Bone marrow cells are induced to cycle following administration of IL-I. J. Immunol. 139, 1861-1866 (1987).
23. C. Lerner and D. E. Harrison, 5-Fluorouracil spares hematopoietic stem cells responsible for long term repopulation. Exp. Hematol. 18, 114-120 (1990).
24. G. S. Hodgson and T. R. Bradley, Properties of hemopoietic stem cells surviving 5-fluorouracil treatment: evidence for pre-CFU-S cell? Nature 281, 381-382 (1979).
25. G. Van Zant, Studies of hematopoietic stem cells spared by 5-fluorouracil. J. Exp. Med. 159, 679-690 (1984).
26. J. E. Till and E. A. McCulloch, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 216-222 (1961).
27. S. W. Quian, P. Kondaiah, A. B. Roberts and M. B. Sporn, cDNA cloning by PCR of rat transformins growth factor β-1. Nucleic Acids Res. 18, 3059-3065 (1990).
28. P. Chomczynski, A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15, 532-537 (1993).
29. R. Neta, J. J. Oppenheim, R. D. Schreiber, R. Chizzonite, G. D. Ledney and T. J. MacVittie, Role of cytokines (interleukin 1, tumor necrosis factor and transforming growth factor β) in natural and lipopolysaccharide-enhanced radioresistance. J. Exp. Med. 173, 1177-1182 (1991).
30. J. D. Cashman, A. C. Eaves, E. W. Raines, R. Ross and C. J. Eaves. Hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF β. Blood 72, 96-103 (1990).
31. 1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90, 10315-10319 (1993).
32. T. R. Bradley, G. S. Hodgson and I. Bertoncello, Characteristic of primitive macrophage progenitor cells with high proliferative potential: Relationship to cells with marrow repopulating ability in 5-fluorouracil treated mouse bone marrow. In Experimental Hematology Today (S. J. Baum, G. D. Ledney and D. W. van Bekkum, Eds.), pp. 285-297. Springer International, Berlin, 1982.
33. C. M. Dubois, F. W. Ruscetti, J. R. Keller, J. J. Oppenheim, K. Hestdal, R. Chizzonite and R. Neta, In vivo IL-1 administration indirectly promotes type II IL-1 receptor expression on hematopoietic progenitor cells. Blood 78, 2841-2848 (1991).
34. J. R. Keller, C. Mantel, G. K. Sing, L. R. Elliingsworth, S. K. Ruscetti and F. W. Ruscetti, Transforming growth factor β1 selectively regulates early hematopoietic progenitors and inhibits the growth of IL-3-dependent mveloid leukemia cell lines. J. Exp. Med. 168, 737-743 (1988).
35. O. Ottman and L. Pellus, Differential proliferative effects of transforming growth factor β on human hematopoietic progenitor cells. J. Immunol. 140, 2661-2668 (1988).
36. J. R. Keller, S. E. W. Jacobsen, C. M. Dubois, K. Hestdal and F. W. Ruscetti, Transforming growth factor β: A bidirectional regulator of hematopoietic cell growth. Int. J. Cell Cloning 10, 2-11 (1991).
37. J. R. Keller, I. K. McNiece, K. T. Sill, L. R. Ellingsworth, P. J. Quesenberry, G K. Sing and F. W. Ruscetti, Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood 75, 596-602 (1990).
38. C. M. Dubois, F. W. Ruscetti, J. Stankova and J. R. Keller, Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83, 3138-3145 (1994).
39. S. E. W. Jacobsen, S. W. Ruscetti, C. M. Dubois, J. Lee, T. C. Boone and J. R. Keller, Transforming growth factor-β trans-modulates the expression of colony stimulation factor receptors on murine hematopoietic progenitor cell lines. Blood 77, 1706-1716 (1991).
40. C. M. Dubois, F. W. Ruscetti, E. W. Palaszynski, L. A. Falk, J. J. Oppenheim and J. R. Keller, Transforming growth factor-β is a potent inhibitor of interleukin-1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172, 737-747 (1990).
41. M. C. Heinrich, D. C. Dooley and W. W. Keeble, Transforming growth factor β1 inhibits expression of the gene products for Steel factor and its receptor (c-kit). Blood 85, 1769-1780 (1995).
42. G. J. Hannon and D. Beach, p15 INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
43. M. Peter and I. Herskowitz, Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79, 181-184 (1994).
44. J. R. Keller, S. E. W. Jacobsen, K. T. Sill, L. R. Ellingsworth and F. W. Ruscetti, Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte-macrophage colony stimulating factor. Proc. Natl. Acad. Sci. USA 88, 7190-7194 (1991).
45. C. Gasparetto, J. Laver, M. Abboud, A. Gillio, C. Smith, R. J. O'Reilly and M. A. Moore, Effects of interleukin-1 on hematopoietic progenitors: Evidence of stimulatory and inhibitory activities in a primate model. Blood 74, 547-550 (1989).
46. M. A. S. Moore. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78, 1-19 (1991).
47. L. M. Pelus, Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming-units-granulocyte, macrophage) after acute administration of recombinant human IL-1 alpha. J. Immunol. 143, 4171-4179 (1989).
48. R. R. Patil and R. F. Borch, Granulocyte-macrophage colony-stimulating factor expression by human fibroblasts is both upregulated and subsequently downregulated by interleukin-1. Blood 85, 80-86 (1995).